Abstract
Current ACC guidelines have class 2A recommendations that pretreatment with class 1c or class 3 anti-arrhythmic drugs can enhance the acute success rate of electrical cardioversion of atrial fibrillation. Efficacy of pretreatment with Dronedarone, a new class 3 anti-arrhythmic drug is currently
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
